Det Farmaceutiske Benefits Scheme (PBS) forbruger omkring 14 procent af den samlede offentlige sundhedsudgifter og er vokset betydeligt i både række lægemidler, der er omfattet, og udgifter, da det først blev indført i 1950. Fortalere for narkotika prisregulering hævder, at narkotika beslutningstagere hæve priserne til gavne værdien af deres aktier og investere lidt af deres overskud i udvikling og forskning af nye lægemidler. Modstandere af regulering hævder, at forbrugerne er afhængige af narkotika virksomheder til at udvikle nye lægemidler og begrænsende priserne vil forhindre nye livreddende medicin fra at blive udviklet.
@ISIDEWITH6mos6MO
How might regulating drug prices change people's trust in the healthcare system?
@ISIDEWITH6mos6MO
How would you feel if someone you love couldn’t access a medicine due to its high cost?
@ISIDEWITH6mos6MO
Do you believe that life-saving medications should be affordable for all, even if it impacts drug company profits?
@ISIDEWITH6mos6MO
Should governments have the right to set prices for drugs, or should it be left to the free market?
@ISIDEWITH6mos6MO
Do companies deserve to charge high prices for innovative medicines if they invested millions in research and development, or is that unfair to patients?
@ISIDEWITH6mos6MO
If you were faced with choosing between two expensive drugs, how would you make that decision and what factors would matter most to you?
@ISIDEWITH6mos6MO
Do you think drug pricing is a moral issue, and why or why not?
@ISIDEWITH6mos6MO
Is it fair that prices for the same drugs can be drastically different in other countries, and how does that make you feel as a consumer?
@ISIDEWITH6mos6MO
Do you think there's a way to balance making drugs affordable without discouraging companies from developing new treatments?
@ISIDEWITH6mos6MO
Have you or someone you know ever struggled with the high cost of a necessary medication, and how did that affect you emotionally?
